Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis
Condition(s):Secondary Hyperparathyroidism, Chronic Kidney DiseaseLast Updated:June 29, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Secondary Hyperparathyroidism, Chronic Kidney DiseaseLast Updated:June 29, 2020Completed
Condition(s):Secondary HyperparathyroidismLast Updated:January 25, 2016Completed
Condition(s):Primary Hyperparathyroidism; Bone MetabolismLast Updated:March 16, 2016Unknown status
Condition(s):Secondary Hyperparathyroidism; Diabetic NephropathiesLast Updated:May 2, 2017Completed
Condition(s):Hyperparathyroidism, PrimaryLast Updated:January 30, 2024Recruiting
Condition(s):Chronic Kidney Disease, Secondary HyperparathyroidismLast Updated:June 29, 2020Terminated
Condition(s):Primary HyperparathyroidismLast Updated:December 5, 2022Unknown status
Condition(s):Secondary Hyperparathyroidism; HemodialysisLast Updated:July 11, 2011Completed
Condition(s):Hyperparathyroidism; Hypercalcemia; Parathyroid Neoplasm; Multiple Endocrine Neoplasia; MEN1Last Updated:June 7, 2022Completed
Condition(s):Hyperparathyroidism; Kidney DiseaseLast Updated:December 6, 2012Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.